Advice to clinicians about leptospirosis in U.S. travelers returning from northern Israel
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All
i

Advice to clinicians about leptospirosis in U.S. travelers returning from northern Israel

Filetype[PDF-457.01 KB]


  • English

  • Details:

    • Description:
      Distributed via the CDC Health Alert Network September 7, 2018, 1345 ET (1:45 PM ET) CDC HAN-00414 The Israeli Ministry of Health is reporting an outbreak of leptospirosis in persons with exposure to natural water sources in the Golan Heights region of northern Israel after July 1, 2018. As of September 6, 2018, three persons with leptospirosis who traveled to Israel have been identified in the United States, with additional suspected cases reported and under investigation. Early symptoms of leptospirosis include fever, headache, chills, muscle aches, vomiting, diarrhea, cough, conjunctival suffusion (conjunctival redness without exudates), jaundice, and sometimes a rash. Clinicians should consider leptospirosis as a diagnosis in any patient who develops an acute febrile illness within 4 weeks of travel to one of the areas in northern Israel listed below since July 1, 2018. Background Seven recreational water sites in the Golan Heights region have been linked to the outbreak: • Gilabun (Jilbon) • Yarden (Jordan) Park • Majrase (Majrase-Beteha Nature Reserve) • Meshushim (Meshushim Nature Reserve) • Yehudiya (Yehudia Nature Reserve) • Zaki (Zakhi) • Zavitan
    • Series:
    • Document Type:
    • Place as Subject:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov